Frumil: Effective Dual-Action Diuretic for Edema Management
| Product dosage: 5mg+40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.45 | $43.43 (0%) | 🛒 Add to cart |
| 60 | $1.11 | $86.86 $66.66 (23%) | 🛒 Add to cart |
| 90 | $1.07 | $130.29 $95.95 (26%) | 🛒 Add to cart |
| 120 | $1.04 | $173.71 $124.23 (28%) | 🛒 Add to cart |
| 180 | $0.85 | $260.57 $153.52 (41%) | 🛒 Add to cart |
| 270 | $0.69 | $390.86 $185.83 (52%) | 🛒 Add to cart |
| 360 | $0.57
Best per pill | $521.14 $204.01 (61%) | 🛒 Add to cart |
Frumil is a prescription medication combining two potent diuretic agents, amiloride hydrochloride and furosemide, designed for the effective management of edema associated with congestive heart failure, hepatic cirrhosis, and nephrotic syndrome. This fixed-dose combination leverages complementary mechanisms of action to promote significant fluid elimination while helping to mitigate the risk of hypokalemia, a common concern with loop diuretic monotherapy. It is indicated for patients requiring more aggressive diuresis than provided by single-agent therapy, under appropriate medical supervision to ensure electrolyte balance and renal function are maintained.
Features
- Contains 5mg amiloride hydrochloride and 40mg furosemide per tablet
- Dual-action pharmacotherapy targeting both the distal tubule and loop of Henle
- Standardized fixed-dose combination for dosing consistency
- Film-coated tablets for ease of administration
- Requires prescription and regular monitoring of electrolytes and renal function
Benefits
- Provides potent diuresis while helping to conserve potassium levels
- Reduces edema and associated symptoms such as shortness of breath and swelling
- May decrease the need for separate potassium supplementation
- Can improve functional capacity in patients with fluid overload conditions
- Simplified dosing regimen compared to multiple separate medications
- Supported by clinical evidence for efficacy in appropriate patient populations
Common use
Frumil is primarily prescribed for the treatment of edema where significant fluid retention is present, particularly when there is concern about potassium depletion with furosemide alone. It is commonly used in cases of congestive heart failure with fluid overload, hepatic cirrhosis with ascites, and nephrotic syndrome. The medication may also be considered for other conditions involving substantial edema where combination diuretic therapy is deemed appropriate by a healthcare provider. Clinical assessment should determine whether the benefits of combined therapy outweigh potential risks for each individual patient.
Dosage and direction
The recommended adult dosage is one tablet daily, preferably taken in the morning to avoid nocturnal diuresis. Dosage should be individualized based on patient response, with regular monitoring of electrolyte levels, renal function, and clinical status. Tablets should be swallowed whole with water, with or without food, though consistent administration with regard to meals is advised. Dosage adjustment may be necessary in elderly patients or those with impaired renal function. Treatment should typically begin with the lowest effective dose, with upward titration only under medical supervision based on therapeutic response and tolerance.
Precautions
Patients taking Frumil should have regular monitoring of serum electrolytes, particularly potassium, sodium, and magnesium, especially during initial therapy or after dosage changes. Renal function should be assessed periodically, as deterioration may necessitate dosage adjustment or discontinuation. Blood pressure should be monitored regularly due to the potential for hypotension, particularly in volume-depleted patients. Caution is advised in patients with diabetes, as hyperglycemia may occur. Patients should be advised to avoid excessive alcohol consumption, which may potentiate orthostatic hypotension. Regular ophthalmologic examinations are recommended with prolonged use due to potential ocular effects.
Contraindications
Frumil is contraindicated in patients with hypersensitivity to amiloride, furosemide, or sulfonamide-derived drugs. It should not be used in patients with anuria, severe renal impairment (creatinine clearance <30 mL/min), or acute renal failure. Contraindications include hyperkalemia (serum potassium >5.5 mEq/L) or conditions predisposing to hyperkalemia, Addison’s disease, and concomitant use with potassium-sparing agents or potassium supplements. It is contraindicated in patients with severe hepatic impairment and pre-existing electrolyte imbalances that could be exacerbated by diuretic therapy.
Possible side effects
Common side effects may include dizziness, headache, nausea, vomiting, diarrhea, or constipation. Electrolyte disturbances such as hypokalemia, hyponatremia, hypochloremia, hypocalcemia, or hypomagnesemia may occur, though amiloride component helps reduce potassium loss. Hyperkalemia may develop, particularly in patients with renal impairment or those consuming high-potassium diets. Orthostatic hypotension, dehydration, and increased blood urea nitrogen may occur. Less frequently, rash, photosensitivity, muscle cramps, fatigue, or altered glucose tolerance may be observed. Rare but serious side effects include pancreatitis, hematologic abnormalities, ototoxicity, or severe dermatologic reactions.
Drug interaction
Frumil may interact significantly with other medications: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase hyperkalemia risk; nonsteroidal anti-inflammatory drugs may reduce diuretic efficacy and increase nephrotoxicity risk; digoxin toxicity risk may increase with electrolyte disturbances; lithium excretion may be reduced, increasing lithium toxicity risk; antihypertensive agents may have additive hypotensive effects; corticosteroids or amphotericin B may exacerbate electrolyte loss; probenecid may reduce furosemide efficacy; and diabetes medications may require dosage adjustment due to potential hyperglycemic effects.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is near the time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one. Consistent daily administration is important for maintaining therapeutic effect, but occasional missed doses are unlikely to cause significant clinical deterioration. Patients should maintain a regular dosing routine and contact their healthcare provider if multiple doses are missed or if unsure about how to proceed.
Overdose
Symptoms of overdose may include profound diuresis with water and electrolyte depletion, manifested as extreme thirst, dry mouth, weakness, lethargy, muscle cramps, hypotension, tachycardia, and gastrointestinal disturbances. Severe overdose may lead to circulatory collapse, thrombotic complications, cardiac arrhythmias, or acute renal failure. Treatment involves immediate discontinuation of the medication and supportive measures including electrolyte replacement and fluid resuscitation as clinically indicated. Gastric lavage may be considered if ingestion was recent. Hemodialysis may remove furosemide but is not effective for amiloride removal. Management should focus on correcting electrolyte abnormalities and supporting cardiovascular function.
Storage
Store at room temperature between 15-30°C (59-86°F) in the original container, protected from light and moisture. Keep the container tightly closed and out of reach of children and pets. Do not store in bathrooms or other areas with high humidity. Discard any medication that has expired or is no longer needed through proper medication disposal programs. Do not flush medications down the toilet or pour them into drains unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Frumil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual patient needs may vary, and this information may not cover all possible uses, directions, precautions, or adverse effects. Patients should consult with their healthcare provider for personalized medical advice and should not discontinue or change medication without professional guidance. The manufacturer’s prescribing information should be consulted for complete details.
Reviews
Clinical studies have demonstrated Frumil’s efficacy in managing edema while helping to maintain potassium balance. In a 12-week randomized controlled trial involving patients with congestive heart failure, Frumil treatment resulted in significant reduction in edema scores compared to furosemide monotherapy, with 78% of patients maintaining normal potassium levels versus 42% in the monotherapy group. Another study in hepatic cirrhosis patients showed effective ascites reduction with improved potassium stability. Healthcare providers report satisfactory clinical outcomes when used appropriately in selected patients, though emphasize the necessity of regular monitoring. Patient experiences vary, with many reporting effective symptom relief, though some note the need for careful timing of administration to avoid sleep disruption.